Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

2 Profitable Stocks to Consider Right Now and 1 We Question

By: StockStory

June 02, 2026 at 00:38 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MRVL Cover Image

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here are two profitable companies that balance growth and profitability and one best left off your watchlist.

One Stock to Sell:

Zimmer Biomet (ZBH)

Trailing 12-Month GAAP Operating Margin: 14%

With a history dating back to 1927 and a presence in over 100 countries worldwide, Zimmer Biomet (NYSE: ZBH) designs and manufactures orthopedic products including knee and hip replacements, surgical tools, and robotic technologies for joint reconstruction and spine surgeries.

Why Does ZBH Worry Us?

Muted 5.6% annual revenue growth over the last five years shows its demand lagged behind its healthcare peers
Estimated sales growth of 2.4% for the next 12 months implies demand will slow from its two-year trend
Underwhelming 4.2% return on capital reflects management’s difficulties in finding profitable growth opportunities

Zimmer Biomet is trading at $82.77 per share, or 9.7x forward P/E. Check out our free in-depth research report to learn more about why ZBH doesn’t pass our bar.

Two Stocks to Watch:

Marvell Technology (MRVL)

Trailing 12-Month GAAP Operating Margin: 16%

Moving away from a low margin storage device management chips in one of the biggest semiconductor business model pivots of the past decade, Marvell Technology (NASDAQ: MRVL) is a fabless designer of special purpose data processing and networking chips used by data centers, communications carriers, enterprises, and autos.

Why Are We Positive on MRVL?

Annual revenue growth of 22.9% over the past five years was outstanding, reflecting market share gains this cycle
Demand for the next 12 months is expected to accelerate above its two-year trend as Wall Street forecasts robust revenue growth of 45.4%
Operating profits and efficiency rose over the last five years as it benefited from some fixed cost leverage

Marvell Technology’s stock price of $219.61 implies a valuation ratio of 45.2x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Taboola (TBLA)

Trailing 12-Month GAAP Operating Margin: 6.1%

Often appearing as those "You May Also Like" or "Recommended For You" boxes at the bottom of news articles, Taboola (NASDAQ: TBLA) operates a digital platform that recommends personalized content to users across publisher websites, helping both publishers monetize their sites and advertisers reach target audiences.

Why Does TBLA Stand Out?

Market share has increased this cycle as its 13.1% annual revenue growth over the last two years was exceptional
Free cash flow margin grew by 8.8 percentage points over the last five years, giving the company more chips to play with
Improving returns on capital suggest its past investments are beginning to deliver value

At $4.96 per share, Taboola trades at 0.7x trailing 12-month price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	253.79	+3.77 (1.51%)
AAPL	311.23	+0.97 (0.31%)
AMD	523.20	-19.32 (-3.56%)
BAC	54.17	+1.77 (3.38%)
GOOG	369.27	+13.59 (3.82%)
META	627.57	+4.59 (0.74%)
MSFT	428.05	+0.71 (0.17%)
NVDA	218.66	+3.91 (1.82%)
ORCL	236.34	+6.01 (2.61%)
TSLA	418.45	-5.25 (-1.24%)